TARDBP and amyotrophic lateral sclerosis: Accordingly, it will be important to determine if aberrant Wnt activation is observed in other contexts of TDP-43 dysfunction, including but not limited to iSNs from patients with familial and sporadic forms of ALS, and to test the efficacy of Wnt inhibition in mitigating TDP-43 splicing deficiencies.